Utility of the “Modified Erasmus <scp>GBS</scp> Respiratory Insufficiency Score” in Axonal and Demyelinating Guillain–Barré Syndrome
The mEGRIS is useful for predicting MV risk in patients with AMAN, as well as AIDP. Close monitoring was required for patients who were classified as moderate or high-risk by mEGRIS, irrespective of GBS subtypes.
Authors
- Tomoki Suichi (ORCID: https://orcid.org/0000-0002-9575-9444)
- YUKI SHIKO
- Koji Takahashi (ORCID: https://orcid.org/0000-0001-8134-8524)
- Yukari Sekiguchi (ORCID: https://orcid.org/0000-0002-8531-2446)
- Satoshi Kuwabara
- Marie Morooka
- Sonoko Misawa
Institutions
- Chiba University (JP)
- Tokyo University of Science (JP)
- Chiba University Hospital (JP)
- JR Tokyo General Hospital (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Journal of the Peripheral Nervous System
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1111/jns.70096
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00